- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05823493
Effect of Schroth Exercises Combined With Laser Acupuncture Therapy in Adolescent Idiopathic Scoliosis
Schroth Exercises Combined With Laser Acupuncture Therapy
The goal of this clinical trial] is to explore the clinical effect of laser acupuncture combined with Schroth training on adolescent idiopathic scoliosis (AIS) . The main question[s] it aims to answer are:
- The effects of Schroth exercises on Cobb angles, angle of trunk rotation, spinal mobility, gait parameters and clinical efficacy in patients with AIS.
- Laser acupuncture combined with Schroth method on Cobb angles, angle of trunk rotation, spinal mobility, gait parameters and clinical efficacy in patients with AIS.
Participants will received Schroth exercise therapy and laser acupuncture therapy (MLS laser).
If there is a comparison group: Researchers will compare received Schroth exercise therapy to see the effects of Schroth exercises and laser acupuncture combined with Schroth method on Cobb angles, angle of trunk rotation, spinal mobility, gait parameters and clinical efficacy in patients with AIS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dalian, China
- Dalian Second People's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adolescent idiopathic scoliosis patients without history of traumas
- positive Adam's Forward Bend Test, Cobb Angle>10°
Exclusion Criteria:
- functional scoliosis and other structural scoliosis
- Previous history of scoliosis surgery
- Wearing braces and being treated in other ways
- Unable to complete PSSE training actions as required
- Complicated with serious heart, liver, kidney and other systemic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: the control group
|
The Schroth classification criteria includes four curve patterns that are determined with reference to the location of the curves, the importance of lumbar and thoracic prominences, and the effect of the scoliosis on the pelvis.
|
|
Experimental: the experimental group
|
The Schroth classification criteria includes four curve patterns that are determined with reference to the location of the curves, the importance of lumbar and thoracic prominences, and the effect of the scoliosis on the pelvis.
Laser therapy was performed w ith a dual wavelength, high power IR laser (Multiwave Locked System (MLS®) laser, Mphi, ASA srl, Vicenza, Italy) and the laser acupuncture points include DU2, GB30, DU9, SP6, LR8, DU6, DU4, DU12.
Laser puncture acupuncture points had been identified according to Traditional Chinese Medicine (TCM) and treated with handpiece optical group following the detailed treatment parameters: 900Hz, FPW mode, 60 s per point, 29.12J, spot size 3 cm2, energy density 27J/cm2.
All treatments are performed five times in a week for 4 consecutive weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cobb angle(°)
Time Frame: before the whole treatment cycle
|
Draw a line through the spine on the upper surface of the upper vertebra and the lower surface of the lower vertebra on the X-ray film, and make the vertical line of the above two lines, and measure the angle between the two vertical lines.
All radiographs are measured three times by a professional physician with the same protractor, and the average value is recorded
|
before the whole treatment cycle
|
|
Cobb angle(°)
Time Frame: 6 months after treatment
|
Draw a line through the spine on the upper surface of the upper vertebra and the lower surface of the lower vertebra on the X-ray film, and make the vertical line of the above two lines, and measure the angle between the two vertical lines.
All radiographs are measured three times by a professional physician with the same protractor, and the average value is recorded
|
6 months after treatment
|
|
Cobb angle(°)
Time Frame: 12 months after treatment
|
Draw a line through the spine on the upper surface of the upper vertebra and the lower surface of the lower vertebra on the X-ray film, and make the vertical line of the above two lines, and measure the angle between the two vertical lines.
All radiographs are measured three times by a professional physician with the same protractor, and the average value is recorded
|
12 months after treatment
|
|
Trunk rotation angle(°)
Time Frame: before the whole treatment cycle
|
Trunk rotation angle (ATR) is measured with scoliosis instrument to quantitatively evaluate the chest rotation angle and waist rotation angle.
|
before the whole treatment cycle
|
|
Trunk rotation angle(°)
Time Frame: 6 months after treatment
|
Trunk rotation angle (ATR) is measured with scoliosis instrument to quantitatively evaluate the chest rotation angle and waist rotation angle.
|
6 months after treatment
|
|
Trunk rotation angle(°)
Time Frame: 12 months after treatment
|
Trunk rotation angle (ATR) is measured with scoliosis instrument to quantitatively evaluate the chest rotation angle and waist rotation angle.
|
12 months after treatment
|
|
Musculoskeletal stiffness
Time Frame: before the whole treatment cycle
|
Use PulStarG3 system (Sense Technology Inc) to evaluate the musculoskeletal stiffness of each spinal segment.
The handheld pulse head presses on the patient and provides a single low-energy pulse to the vertebral layer of interest.
The force sensor in the pulse head measures the resistance to the pulse and transmits the analysis results to a digital computer, which can be considered as a computer-assisted spinal palpation in a series of bar graphs (abnormal musculoskeletal hardness is shown in the red bar and normal musculoskeletal hardness is shown in the green bar).
|
before the whole treatment cycle
|
|
Musculoskeletal stiffness
Time Frame: 6 months after treatment
|
Use PulStarG3 system (Sense Technology Inc) to evaluate the musculoskeletal stiffness of each spinal segment.
The handheld pulse head presses on the patient and provides a single low-energy pulse to the vertebral layer of interest.
The force sensor in the pulse head measures the resistance to the pulse and transmits the analysis results to a digital computer, which can be considered as a computer-assisted spinal palpation in a series of bar graphs (abnormal musculoskeletal hardness is shown in the red bar and normal musculoskeletal hardness is shown in the green bar).
|
6 months after treatment
|
|
Musculoskeletal stiffness
Time Frame: 12 months after treatment
|
Use PulStarG3 system (Sense Technology Inc) to evaluate the musculoskeletal stiffness of each spinal segment.
The handheld pulse head presses on the patient and provides a single low-energy pulse to the vertebral layer of interest.
The force sensor in the pulse head measures the resistance to the pulse and transmits the analysis results to a digital computer, which can be considered as a computer-assisted spinal palpation in a series of bar graphs (abnormal musculoskeletal hardness is shown in the red bar and normal musculoskeletal hardness is shown in the green bar).
|
12 months after treatment
|
|
Gait(stride length (m))
Time Frame: before the whole treatment cycle
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
before the whole treatment cycle
|
|
Gait(stride time(s))
Time Frame: before the whole treatment cycle
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
before the whole treatment cycle
|
|
Gait(walking speed(m/s))
Time Frame: before the whole treatment cycle
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
before the whole treatment cycle
|
|
Gait(stride length (m))
Time Frame: 6 months after treatment
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
6 months after treatment
|
|
Gait(stride time(s))
Time Frame: 6 months after treatment
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
6 months after treatment
|
|
Gait(walking speed(m/s))
Time Frame: 6 months after treatment
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
6 months after treatment
|
|
Gait(stride length (m))
Time Frame: 12 months after treatment
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
12 months after treatment
|
|
Gait(stride time(s))
Time Frame: 12 months after treatment
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
12 months after treatment
|
|
Gait(walking speed(m/s))
Time Frame: 12 months after treatment
|
collected by wearable devices (micro-electro-mechanical systems, MEMS), the sampling frequency is set at 20 Hz, and transmitted to the computer server according to the manufacturer's protocol.
The collected gait parameters include average pressure distribution, stride length, stride length and walking speed.
|
12 months after treatment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DLSP001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.